Alafair Biosciences Celebrates Showcase of Achievement
Alafair Biosciences, Inc., a forefront player in hydrogel technology for medical applications, has been recognized in the esteemed Longhorn 100, affirming its position as one of the fastest-growing businesses led by alumni of the University of Texas at Austin. This prestigious acknowledgment comes as Alafair proudly sits at #2 among outstanding emerging companies, signifying its remarkable growth trajectory, innovative practices, and strong connections to the university's vibrant community.
Innovative Journey from Lab to Market
Alafair's story is a true representation of success, transforming a groundbreaking hydrogel technology from a university lab into a practical solution for medical needs. Co-founder and co-creator of Alafair's hydrogel technology, Sarah Mayes, PhD, who holds both undergraduate and doctoral degrees from UT Austin, reflects on the indispensable role the university has played in their journey. "The resources and guidance provided by various university offices, including Discovery to Impact and the Texas Innovation Center, have been instrumental in fortifying Alafair's success from its nascent stages. Their unwavering support allowed us to unlock potential as an early-stage company, and we are grateful for the trust placed in us," stated Dr. Mayes.
Commitment to Longhorn Spirit and Innovation
Alafair's foundation and leadership teams encompass several proud alumni from UT, with headquarters situated in Austin. The firm remains inspired by the Longhorn values of resilience and forward-thinking. John Joyoprayitno, President & CEO of Alafair Biosciences, expressed his pride in the company's standing among esteemed peers, stating, "Being recognized #2 amongst such remarkable organizations is a true honor. Our deeply-rooted ties to UT enrich our journey, and we are passionate about embodying the Longhorn motto of innovation and excellence. What starts here truly changes the world, and we strive to advance that mission daily."
Acknowledgement of Business Growth
The Longhorn 100 is an initiative that honors businesses driven by alumni of UT Austin, celebrating their exceptional growth, leadership, and significant contributions to their respective industries. The rankings were announced during a yearly awards event, acknowledging the commitment and achievements of these remarkable companies. Alafair's inclusion in this year's lineup follows a spectacular year of growth, with the company achieving a 51% surge in year-over-year revenue from VersaWrap Hydrogel Sheet sales and over 26,000 implants distributed across the nation.
About Alafair Biosciences, Inc.
Alafair is a privately held enterprise that innovates and markets medical devices utilizing its proprietary hydrogel technology. The core mission of Alafair is to revolutionize surgical methods by offering superior solutions that elevate patient outcomes while enhancing the safety of soft tissue procedures. Their products are widely available through a broad network of independent distributors throughout the United States.
About VersaWrap Hydrogel Sheet
The VersaWrap Hydrogel Sheet represents an FDA-cleared medical device implant made from hyaluronic acid and alginate that provides effective tissue management. The VersaWrap Tendon Protector is specifically designed to manage and safeguard injured tendons without significant tissue loss, while the VersaWrap Nerve Protector aims to assist peripheral nerve injuries, all while ensuring ease of tissue movement to improve surgery outcomes.
Frequently Asked Questions
What is Alafair Biosciences?
Alafair Biosciences is a medical device company specializing in hydrogel technology for improved surgical care.
What recognition did Alafair receive recently?
Alafair was ranked #2 on the Longhorn 100 list of fast-growing businesses led by UT Austin alumni.
Who is the CEO of Alafair Biosciences?
John Joyoprayitno serves as the President and CEO of Alafair Biosciences.
What does the VersaWrap Hydrogel Sheet do?
VersaWrap Hydrogel Sheet is designed for tissue protection during surgeries and helps in managing injuries involving tendons and nerves.
How has Alafair performed in terms of growth?
In the past year, Alafair achieved 51% revenue growth and notable implant distribution across the nation.
